Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69,110,956
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
435,988
-
Shares change
-
+249,571
-
Total reported value, excl. options
-
$8,893,000
-
Value change
-
+$5,089,665
-
Number of buys
-
24
-
Number of sells
-
-3
-
Price
-
$20.39
Significant Holders of PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) as of Q1 2017
29 filings reported holding PLSE - PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share as of Q1 2017.
PULSE BIOSCIENCES, INC. - Common Stock, par value $0.001 per share (PLSE) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 435,988 shares
of 69,110,956 outstanding shares and own 0.63% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (178,908 shares), GEODE CAPITAL MANAGEMENT, LLC (42,456 shares), CADENCE CAPITAL MANAGEMENT LLC (30,230 shares), UBS Group AG (25,786 shares), GOLDMAN SACHS GROUP INC (22,983 shares), JW Asset Management, LLC (21,954 shares), BlackRock Inc. (15,402 shares), TFS CAPITAL LLC (14,019 shares), MILLENNIUM MANAGEMENT LLC (11,975 shares), and JANE STREET GROUP, LLC (11,908 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.